Cell signaling through membrane mucins

BioEssays

Volumn 25, Issue 1, 2003, Pages 66-71

  Carraway, Kermit L ^a   Ramsauer, Victoria P ^a   Haq, Bushra ^a   Carothers Carraway, Coralie A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037235146     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10201     Document Type: Review

References (47)

1. Strous G, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992;27:57-92.
2. McNeer RR, Price-Schiavi S, Komatsu M, Fregien N, Carraway CAC, Carraway KL. Sialomucin complex in tumors and tissues. Front Biosci 1997;2:449-459.
3. Gendler SJ, Spicer AP. Epithelial mucin genes. Ann Rev Physiol 1995;57:607-634.
4. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CAC, Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia:to protect and to survive. Prog Nucleic Acids Res Molec Biol 2001;171:149-185.
5. Komatsu M, Yee L, Carraway KL. Overexpression of sialomucin complex, a rat homolog of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res 1999;59:2229-2236.
6. Price-Schiavi SA, Jepson S, Li P, Arango M, Rudland PS, Yee L, Carraway KL. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Int J Cancer 2002;99:783-791.
7. Boshell M, Lalani E-N, Pemberton L, Burchell J, Gendler S, Taylor-Papadimitriou J. The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem Biophys Res Commun 1992;185:1-8.
8. Rossi EA, McNeer R, Price-Schiavi SA, Komatsu M, Van den Brande JMH, Thompson JF, Carraway CAC, Fregien NL, Carraway KL. Sialomucin complex, a heterodimeric glycoprotein complex:Expression as a soluble, secretable form in lactating mammary gland and colon. J Biol Chem 1996;271:33476-33485.
9. Williams CJ, Wreschner DH, Tanaka A, Tsarfaty I, Keydar I, Dion AS. Multiple protein forms of the human breast tumor-associated epithelial membrane antigen (EMA) are generated by alternative splicing and induced by hormonal stimulation. Biochem Biophys Res Commun 1990;170:1331-1338.
10. Moniaux N, Escande F, Batra SK, Porchet N, Laine A, Aubert J-P. Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur J Biochem 2000;267:4536-4544.
11. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001;6:339-353.
12. Sheng Z, Wu K, Carraway KL, Fregien N. Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex:A new member of the epidermal growth factor superfamily. J Biol Chem 1992;267:16341-16346.
13. Carraway KL III, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Guy PM, Carvajal ME, Fregien N, Carraway CAC, Carraway KL. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem 1999;274:5263-5266.
14. kip, but does not activate mitogen-activated kinase or protein kinase B/Akt pathways. Oncogene 2002;accepted for publication.
15. Klapper LN, Kirschbaum MH, Sela M, Yarden Y. Biochemical and clinical implications of the ErbB/HER signating network of growth factor receptors. Adv Cancer Res 2000;77:25-79.
16. Carraway KL III, Cantley LC. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling. Cell 1994;78:5-8.
17. Ben-Levy R, Paterson HF, Marshall CJ, Yarden Y. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 1994;13:3302-3311.
18. Carraway KL, Carraway CAC. Signaling, mitogenesls and the cytoskeleton:where the action is. BioEssays 1995;17:171-175.
19. Idris N, Carraway KL. Sialomucin complex (Muc4) expression in the rat female reproductive tract. Biol Reprod 1999;61:1431-1438.
20. Price-Schiavi SA, Meller D, Jing X, Merritt J, Carvajal ME, Tseng SCG, Carraway KL. Sialomucin complex at the rat ocular surface:a new model for ocular surface protection. Biochem J 1998;335:457-463.
21. Carraway KL III. Involvement of the neuregulins and their receptors n cardiac and neural development. Bioessays 1996;18:263-266.
22. Idris N, Carraway KL. Regulation of Sialomucin Complex/Muc4 expression in rat uterine luminal epithelial cells by transforming growth factor-β: implications for blastocyst implantation. J Cell Physiol 2000;185:310-316.
23. Komatsu M, Jepson S, Arango ME, Carraway CAC, Carraway KL. Muc4/Sialomucin Complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 2001;20:461-470.
24. Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 1999;11:68-75.
25. Spicer AP, Parry G, Patton S, Gendler SJ. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J Biol Chem 1991;266:15099-15109.
26. Carraway KL, Carraway CAC. Signaling by tyrosine kinases. In: Alison MR, editor. Cancer Handbook: London: Macmillan Reference Ltd, 2002. pp 161-177.
27. Zrihan-Licht S, Baruch A, Elroy-Stein O, Keydar I. Wreschner DH. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett 1994;356:130-136.
28. Meerzaman D, Xing PX, Kim KC. Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin. Am J Physiol 2000;278:L625-629.
29. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem 2001;276:6061-6O64.
30. Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 2001;276:13057-13064.
31. Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway KL 3rd, Kufe D. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 2001;276:35239-35242.
32. Pandey P, Kharbanda S, Kufe D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res 1995;55:4000-4003.
33. Carraway KL, Carraway CAC. Signaling, mitogenesis and tne cytoskeleton:where the action is. Bioessays 1995;17:171-175.
34. Meerzaman D, Shaoiro PS, Kim KC. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. Am J Physiol 2001;281:L86-L91.
35. Wreschner DH, Hareuveni M, Tsarfaty I, Smorodinsky N, Horev J, Zaretsky J, Kotkes P, Weiss M, Lathe R, Dion A. Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem 1990;189:463-473.
36. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J Biol Chem 1997;272:12492-12494.
37. cto. Biochem Biophys Res Commun 2001;281:440-443.
38. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-991.
39. Smalley MJ, Dale TC. Wnt signaling and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2001;6:37-52.
40. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 2000;77:1-24.
41. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-265.
42. Komatsu M, Carraway CAC, Fregien NL, Carraway KL. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J Biol Chem 1997;272:33245-33254.
43. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 1992;17:359-363.
44. Carraway KL, Price-Schiavi SA, Komatsu M, Idris N, Perez A, Li P, Jepson S, Zhu X, Carvajal ME, Carraway CAC. Multiple facets of sialomucin complex/Muc4, a membrane mucin and Erbb2 ligand, in tumors and tissues. Front Biosci 2000;5:d95-107.
45. Ren J, Li Y, Kufe D Protein kinase C δ regulates function of the DF3/ MUC1 carcinoma antigen in β-catenin signaling. J Biol Chem 2002;277:17616-17622.
46. Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol 1998;18:7216-7224.
47. Borg JP, Marchetto S, Le Bivic A, Ollendorff V, Jaulin-Bastard F, Saito H Fournier E, Adelaide J, Margolis B, Birnbaum D. ERBIN:a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nature Cell Biol 2000;2:407-414.